SETMELANOTIDE for Obesity: Side Effects & Safety Data
Lose Weight Fast — The 21-Day Smoothie Diet
36 fat-burning recipes + shopping lists. Results in the first week.
There are 10 adverse event reports in the FDA FAERS database where SETMELANOTIDE was used for Obesity.
Most Reported Side Effects for SETMELANOTIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 53 | 29.1% | 0 | 27 |
| Off label use | 48 | 26.4% | 0 | 21 |
| Skin hyperpigmentation | 43 | 23.6% | 0 | 9 |
| Headache | 27 | 14.8% | 0 | 14 |
| Skin discolouration | 26 | 14.3% | 0 | 7 |
| Diarrhoea | 24 | 13.2% | 0 | 7 |
| Vomiting | 24 | 13.2% | 0 | 12 |
| Fatigue | 23 | 12.6% | 0 | 10 |
| Decreased appetite | 19 | 10.4% | 0 | 11 |
| Injection site pruritus | 19 | 10.4% | 0 | 5 |
| Injection site erythema | 17 | 9.3% | 0 | 5 |
| Injection site pain | 17 | 9.3% | 0 | 6 |
| Dizziness | 15 | 8.2% | 0 | 5 |
| Drug ineffective | 15 | 8.2% | 0 | 6 |
| Injection site bruising | 15 | 8.2% | 0 | 4 |
Other Indications for SETMELANOTIDE
Laurence-moon-bardet-biedl syndrome (94)
Product used for unknown indication (38)
Off label use (17)
Gene mutation (13)
Product use in unapproved indication (9)
Other Drugs Used for Obesity
SEMAGLUTIDE (2,586)
LIRAGLUTIDE (1,090)
BUPROPION\NALTREXONE (726)
TIRZEPATIDE (700)
ORLISTAT (163)
PHENTERMINE (127)
DULAGLUTIDE (109)
METFORMIN (100)
PHENTERMINE\TOPIRAMATE (86)
TOPIRAMATE (86)